Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
I believe this is additional to the 10m production as there will still be a foreseeable demand for our former test too
Only a matter of time before we see the true value of the business. Promo series out soon giving us the exposure we need and next sales update and new product into full production will be the one that gives us that COYS
and look at the exchange rate that will give you a clearer idea of why the prices are reflected the way they are
how do you know its due today mate?
It appears AVCT are so behind the curve and this is evident in the webinar today. Having been in at 40p and sold at 120p I was excited at the prospect but being so late to the party I decided to sell out. Novacyt will be so far ahead in relation to sales plus the development of their new rapid tests. It’s now even more evident that NCYT is the stock to back in the delivery of tests. An interesting poll on Twitter
How many Test at approx £8 each will Novacyt sell before Avacta bring a test to Market. Please include the 10million being produced this month in your answer
Looks like Pauloruros mate as turned up or is this another username for the same person part of TWs clan. LSE need to take a look at these as it’s making a mockery of the chat room, this is mean to be a constructive Board that shouldn’t get clogged up by all this garbage.
Who came in May?
I’ve reported a number of these recent post they aren’t constructive nor ethical nor truthful. This isn’t what this board is for and just cloggs up the feed of genuine shareholders
I have listened to it and feel that his opinion isn’t truly justified. The cash is delivered on performance and only if there is suitable cash flow along with stage payments not all in one go. In regards to CEO ramping I don’t believe that to be the case, he has been pretty quiet it’s only until recently have primer design been more on social media. Obtaining WHO, FDA, NHS, partnership with GSK and AZ, Care Home contract amongst all the other contracts across 100+ Countries hasn’t just come from a guy ramping his flaky business its come from a proven product. What this also does is gives them exposure across all of these other countries for the other revenue streams which aren’t as obviously profitable at Covid 19 at present. If a CEO delivers he should be rewarded not penalised. If he wanted to ramp why are we all here waiting patiently / impatiently for the next RNS. IMO we are well overdue a sales update and there is a reason why. We know the manufacturing arrangements we have and the increase of the test capacity and today’s briefing will only bring more demand with the track and trace. Again IMO AVCT have been ramping with a number of RNSs in a short space of time without having a product to market all in order to increase the MCAP. ODX today another. Why isn’t GM on all the new channels at the moment saying how great their product is, because he’s busy working in the background.
He’s made a spurious claim the try and deramp along with getting people to pay for his podcast. All a money making scheme to get a few quid in the bank
This is old news from the weekend
I believe this holds Novacyt
Investment Trust Polar Capital Technology
Fund Baillie Gifford American
ETF ishares Physical Gold
An interesting find today on how NCYT could be being used to support the NHS all the ducks are getting in line https://twitter.com/ali_maynard1982/status/1243855279772532737?s=21
An interesting find on how NCYT are working with Thermo and Yougene. All the ducks are getting in line
https://twitter.com/ali_maynard1982/status/1243855279772532737?s=21
Here’s some news
https://www.dailymail.co.uk/money/markets/article-8153459/MARKET-REPORT-British-pharma-shares-climb-firms-lead-virus-war.html
4 buys against 1 sale = strong opening